Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA2 | P47869 | 1/20 | 0.40 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9715787 | 0.92 | GABRA2 (0.47) | GABRA2GABRB2 | |
| SCHEMBL346645 | 0.74 | NPC1 (0.40) | ALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL14513797 | 0.73 | PTGS2 (0.52) | GABRA2GABRB2L3MBTL1 | |
| SCHEMBL5594689 | 0.72 | PTGS2 (0.72) | — | |
| SCHEMBL5594568 | 0.72 | PTGS2 (0.72) | — | |
| SCHEMBL5594575 | 0.72 | PTGS2 (0.60) | — | |
| SCHEMBL5594686 | 0.72 | PTGS2 (0.60) | — | |
| SCHEMBL28237437 | 0.71 | GABRA2 (0.52) | GABRA2GABRB2 | |
| SCHEMBL10332224 | 0.69 | GABRA1 (0.46) | GABRB2ALDH1A1RAB9ASMN1; SMN2TDP1 | |
| SCHEMBL18193014 | 0.66 | DRD2 (0.58) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11692131-B2 | Heteroleptic transition metal-carbene complexes and their use in organic light-emitting diodes | UDC IRELAND LIMITED (IE) | 2023-07-04 | — | — | US | disclosed |
| US-20190322929-A1 | HETEROLEPTIC TRANSITION METAL-CARBENE COMPLEXES AND THEIR USE IN ORGANIC LIGHT-EMITTING DIODES | UDC IRELAND LTD (IE) | 2019-10-24 | — | — | US | disclosed |
| US-10385263-B2 | Heteroleptic transition metal-carbene complexes and their use in organic light-emitting diodes (OLEDS) | UDC IRELAND LIMITED (IE) | 2019-08-20 | — | — | US | disclosed |
| CN-101460515-B | Heteroleptic transition metal-carbene complexes and their use in organic light-emitting diodes (OLEDs) | BASF SE | 2013-05-15 | — | — | CN | disclosed |
| US-8373159-B2 | Organic light-emitting diodes comprising carbene-transition metal complex emitter, and at least one compound selected from disilylcarbazoles, disilyldibenzofurans, disilyldibenzothiophenes, disilyldibenzophospholes, disilyldibenzothiophene s-oxides and disilyldibe | BASF SE (DE) | 2013-02-12 | — | — | US | disclosed |
| EP-2007779-B1 | HETEROLEPTIC TRANSITION METAL-CARBENE COMPLEXES AND THEIR USE IN ORGANIC LIGHT-EMITTING DIODES (OLEDS) | BASF SE (DE) | 2012-03-21 | — | — | EP | disclosed |
| US-7989091-B2 | Silanes containing phenothiazine-S-oxide or phenothiazine-S,S-dioxide groups and the use thereof in OLEDs | BASF SE (DE) | 2011-08-02 | — | — | US | disclosed |
| EP-2150556-B1 | SILANES CONTAINING PHENOTHIAZINE-S-OXIDE OR PHENOTHIAZINE-S,S-DIOXIDE GROUPS AND THE USE THEREOF IN OLEDS | BASF SE (DE) | 2011-01-12 | — | — | EP | disclosed |
| US-20100219403-A1 | ORGANIC LIGHT-EMITTING DIODES COMPRISING CARBENE-TRANSITION METAL COMPLEX EMITTERS, AND AT LEAST ONE COMPOUND SELECTED FROM DISILYLCARBAZOLES, DISILYLDIBENZOFURANS, DISILYLDIBENZOTHIOPHENES, DISILYLDIBENZOPHOSPHOLES, DISILYLDIBENZOTHIOPHENE S-OXIDES AND DISILYLDIBENZOTHIOPHENE S,S-DIOXIDES | BASF SE (DE) | 2010-09-02 | — | — | US | disclosed |
| US-20100187980-A1 | SILANES CONTAINING PHENOTHIAZINE-S-OXIDE OR PHENOTHIAZINE-S,S-DIOXIDE GROUPS AND THE USE THEREOF IN OLEDS | BASF SE (DE) | 2010-07-29 | — | — | US | disclosed |
| US-20090096367-A1 | HETEROLEPTIC TRANSITION METAL-CARBENE COMPLEXES AND THEIR USE IN ORGANIC LIGHT-EMITTING DIODES (OLEDS) | BASF SE (DE) | 2009-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090096367-A1 | HETEROLEPTIC TRANSITION METAL-CARBENE COMPLEXES AND THEIR USE IN ORGANIC LIGHT-EMITTING DIODES (OLEDS) | OCIAD2, OCIAD1, ICOSLG | GABRA2 1362/4885GABRB2 1672/4885ALDH1A1 1119/4885 |
| US-20100187980-A1 | SILANES CONTAINING PHENOTHIAZINE-S-OXIDE OR PHENOTHIAZINE-S,S-DIOXIDE GROUPS AND THE USE THEREOF IN OLEDS | OPRD1, PPID, PLOD2 | GABRA2 2152/4885GABRB2 2452/4885ALDH1A1 980/4885 |
| US-20100219403-A1 | ORGANIC LIGHT-EMITTING DIODES COMPRISING CARBENE-TRANSITION METAL COMPLEX EMITTERS, AND AT LEAST ONE COMPOUND SELECTED FROM DISILYLCARBAZOLES, DISILYLDIBENZOFURANS, DISILYLDIBENZOTHIOPHENES, DISILYLDIBENZOPHOSPHOLES, DISILYLDIBENZOTHIOPHENE S-OXIDES AND DISILYLDIBENZOTHIOPHENE S,S-DIOXIDES | DDT, GRIN2B, DRD1 | GABRA2 230/4885GABRB2 83/4885ALDH1A1 1149/4885 |
| US-20190322929-A1 | HETEROLEPTIC TRANSITION METAL-CARBENE COMPLEXES AND THEIR USE IN ORGANIC LIGHT-EMITTING DIODES | CLTB, CLTC, CYBA | GABRA2 565/4885GABRB2 880/4885ALDH1A1 1498/4885 |
| US-11692131-B2 | Heteroleptic transition metal-carbene complexes and their use in organic light-emitting diodes | CLTB, CLTC, CYBA | GABRA2 565/4885GABRB2 880/4885ALDH1A1 1498/4885 |
| US-10385263-B2 | Heteroleptic transition metal-carbene complexes and their use in organic light-emitting diodes (OLEDS) | OCIAD2, OCIAD1, ICOSLG | GABRA2 1362/4885GABRB2 1672/4885ALDH1A1 1119/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.